In animal studies, Wang et al. [26] reported that ASTX could inhibit homocysteine-induced endothelial dysfunction by suppressing the homocysteine-induced activation of the VEGF–VEGFR2–FAK signaling axis in vitro. Here, KDR is linked to endothelial dysfunction.